The Hydropothecary Corp is in the business of producing, marketing and selling of medical marijuana through its indirect wholly-owned subsidiary. The product lines include H2, Decarb, and Elixir No. 1.
Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol CT:HEXO.
$1.63 +0.03 (1.88%)
As of 02/01/2023 16:00:01 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.